同益股份(300538) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 was ¥572,031,440.05, representing an increase of 11.83% compared to ¥511,504,058.47 in the same period last year[7]. - Net profit attributable to shareholders was ¥10,562,582.63, up 10.19% from ¥9,585,627.65 year-on-year[7]. - The net profit after deducting non-recurring gains and losses decreased by 9.50% to ¥8,831,164.07 from ¥9,758,541.43 in the previous year[7]. - Basic earnings per share increased by 10.28% to ¥0.0697 from ¥0.0632 year-on-year[7]. - The total comprehensive income for the period was CNY 13,197,769.72, compared to CNY 10,308,667.24 in the previous year, reflecting a growth of approximately 28.3%[57]. - The company's operating profit for Q1 2021 was CNY 16,075,519.85, an increase from CNY 12,859,849.74 in the same period last year, representing a growth of approximately 25.7%[56]. - The total profit for the period was CNY 16,405,159.88, compared to CNY 12,357,473.64 in the previous year, indicating an increase of about 32.9%[56]. Cash Flow and Assets - The net cash flow from operating activities was -¥136,219,788.69, a significant decline of 427.41% compared to -¥25,828,290.47 in the same period last year[7]. - Cash and cash equivalents increased by 71.26% to 136.85 million yuan from 79.91 million yuan[18]. - The ending balance of cash and cash equivalents was CNY 129.08 million, up from CNY 110.81 million in the previous period[65]. - Total assets at the end of the reporting period reached ¥1,181,904,171.65, a 39.37% increase from ¥848,009,926.73 at the end of the previous year[7]. - The company's total assets increased to CNY 896,040,908.13 from CNY 671,651,737.86 year-over-year, indicating growth in asset base[51]. - The company reported a significant increase in inventory, which rose to 100,240,596.40 RMB from 58,661,466.26 RMB, marking an increase of approximately 70.8%[46]. - Total liabilities rose to CNY 704,035,271.57 from CNY 372,346,512.86, reflecting increased financial obligations[49]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,817[11]. - The largest shareholder, Hua Qingcui, holds 25.70% of the shares, amounting to 38,966,758 shares, with 29,225,068 shares pledged[11]. - The company plans to reduce its shares by up to 2,174,415 shares, accounting for 1.43% of the total share capital, but only 29,000 shares were actually reduced by March 8, 2021[35]. Risk Management and Strategic Initiatives - The company is focusing on enhancing its technical service capabilities and extending its business depth and breadth in response to market demand fluctuations[24]. - The company aims to mitigate raw material procurement risks by actively entering new material fields and developing domestic alternative materials[25]. - The company is implementing measures to manage financial risks, including improving accounts receivable management and establishing a customer risk monitoring mechanism[28]. - The company is addressing international trade risks by establishing a comprehensive risk control system to monitor macroeconomic trends[30]. - The company is committed to developing domestic alternative materials to ensure sufficient supply in response to the impact of the COVID-19 pandemic[31]. Investments and Financing - The company achieved a monthly production capacity exceeding 500 tons for the "Special Engineering Plastic Extrusion Molding Project" in Q1 2021, generating revenue of 15.7471 million RMB[23]. - The total amount of funds raised from the issuance of A-shares was adjusted to not exceed 65239.89 million RMB[32]. - The company plans to apply for a comprehensive credit limit of up to 2 billion RMB from financial institutions[34]. - The company is in the process of applying for a comprehensive credit line from banks and providing guarantees to subsidiaries[37]. - Cash inflow from financing activities reached CNY 242.66 million, significantly higher than CNY 20.16 million in the previous period[65]. - Net cash flow from financing activities was CNY 214.68 million, a substantial increase from negative CNY 2.45 million year-over-year[65]. Research and Development - Research and development expenses for Q1 2021 were CNY 2,875,265.46, compared to CNY 2,357,372.28 in the previous period, reflecting increased investment in innovation[55]. - Research and development expenses increased to CNY 4,069,505.35 from CNY 3,413,176.30, showing a growth of about 19.2% year-over-year[59].